Tapewire

Nasdaq · USD

NVAX

NOVAVAX INC

Export transactions ↓
Tapewire entity
4632
SEC CIK
0001000694
Parsed reports
387

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 20, 2025 Filed Jun 24, 2025 22:37 UTC GrantStock Option (Right to Buy) · Derivative 28,326 $6.42 Strike: $6.42 $181,852.92
Disclosure

SEC source: 0001104659-25-062193 · tm2518838-3_4seq1.xml · derivative · entry 1

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,326

Underlying: Common Stock · 28,326 shares

Expires 2035-06-20

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date.

Read SEC document
June 20, 2025 Filed Jun 24, 2025 22:36 UTC GrantRestricted Stock Units · Derivative 18,884 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-062192 · tm2518838-2_4seq1.xml · derivative · entry 2

Alton Gregg H · CIK 0001334682 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,884

Underlying: Common Stock · 18,884 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F2 · derivative.exercise_date: One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date.

F2 · derivative.expiration_date: One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date.

Read SEC document
June 20, 2025 Filed Jun 24, 2025 22:36 UTC GrantStock Option (Right to Buy) · Derivative 28,326 $6.42 Strike: $6.42 $181,852.92
Disclosure

SEC source: 0001104659-25-062192 · tm2518838-2_4seq1.xml · derivative · entry 1

Alton Gregg H · CIK 0001334682 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,326

Underlying: Common Stock · 28,326 shares

Expires 2035-06-20

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date.

Read SEC document
June 20, 2025 Filed Jun 24, 2025 22:35 UTC GrantRestricted Stock Units · Derivative 18,884 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-062191 · tm2518838-1_4seq1.xml · derivative · entry 2

MCGLYNN MARGARET G · CIK 0001215126 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,884

Underlying: Common Stock · 18,884 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F2 · derivative.exercise_date: One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date.

F2 · derivative.expiration_date: One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date.

Read SEC document
June 20, 2025 Filed Jun 24, 2025 22:35 UTC GrantStock Option (Right to Buy) · Derivative 28,326 $6.42 Strike: $6.42 $181,852.92
Disclosure

SEC source: 0001104659-25-062191 · tm2518838-1_4seq1.xml · derivative · entry 1

MCGLYNN MARGARET G · CIK 0001215126 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,326

Underlying: Common Stock · 28,326 shares

Expires 2035-06-20

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date.

Read SEC document
June 12, 2025 Filed Jun 14, 2025 01:41 UTC Exercise / conversionRestricted Stock Units · Derivative 10,420 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000760 · primary_01.xml · derivative · entry 2

King Rachel K. · CIK 0001589712 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,420 shares

Expires 2034-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2025 Filed Jun 14, 2025 01:41 UTC Exercise / conversionCommon Stock 10,420 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000760 · primary_01.xml · nonDerivative · entry 1

King Rachel K. · CIK 0001589712 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,190

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2025 Filed Jun 14, 2025 01:40 UTC Exercise / conversionRestricted Stock Units · Derivative 10,420 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000759 · primary_01.xml · derivative · entry 2

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,420 shares

Expires 2034-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2025 Filed Jun 14, 2025 01:40 UTC Exercise / conversionCommon Stock 10,420 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000759 · primary_01.xml · nonDerivative · entry 1

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,690

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2025 Filed Jun 14, 2025 01:39 UTC
MOTT DAVID MDirector
Exercise / conversionRestricted Stock Units · Derivative 10,420 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000758 · primary_01.xml · derivative · entry 2

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,420 shares

Expires 2034-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2025 Filed Jun 14, 2025 01:39 UTC
MOTT DAVID MDirector
Exercise / conversionCommon Stock 10,420 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000758 · primary_01.xml · nonDerivative · entry 1

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,890

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2025 Filed Jun 14, 2025 01:36 UTC Exercise / conversionRestricted Stock Units · Derivative 10,420 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000757 · primary_01.xml · derivative · entry 2

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,420 shares

Expires 2034-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2025 Filed Jun 14, 2025 01:36 UTC Exercise / conversionCommon Stock 10,420 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000757 · primary_01.xml · nonDerivative · entry 1

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,340

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:10 UTC Exercise / conversionRestricted Stock Units · Derivative 10,420 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000784 · primary_01.xml · derivative · entry 2

MCGLYNN MARGARET G · CIK 0001215126 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,420 shares

Expires 2034-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:10 UTC Exercise / conversionCommon Stock 10,420 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000784 · primary_01.xml · nonDerivative · entry 1

MCGLYNN MARGARET G · CIK 0001215126 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,588

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:09 UTC Exercise / conversionRestricted Stock Units · Derivative 10,420 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000783 · primary_01.xml · derivative · entry 2

Alton Gregg H · CIK 0001334682 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,420 shares

Expires 2034-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:09 UTC Exercise / conversionCommon Stock 10,420 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000783 · primary_01.xml · nonDerivative · entry 1

Alton Gregg H · CIK 0001334682 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,805

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 25, 2025 Filed Apr 29, 2025 12:08 UTC GrantRestricted Stock Units · Derivative 28,560 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-040669 · tm2513375-2_4seq1.xml · derivative · entry 2

Newton Charles W. · CIK 0001866219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,560

Underlying: Common Stock · 28,560 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.

F3 · derivative.exercise_date: The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date.

F3 · derivative.expiration_date: The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date.

Read SEC document
April 25, 2025 Filed Apr 29, 2025 12:08 UTC GrantStock Option (Right to buy) · Derivative 42,840 $0.00 Strike: $6.70 $0.00
Disclosure

SEC source: 0001104659-25-040669 · tm2513375-2_4seq1.xml · derivative · entry 1

Newton Charles W. · CIK 0001866219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,840

Underlying: Common Stock · 42,840 shares

Expires 2035-04-25

F1 · derivative.exercise_date: The shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest with respect to one-third (1/3) of the shares on each of the first three (3) anniversaries of the April 25, 2025 grant date (the "Grant Date"), in each case subject to continued service on the Company's Board of Directors through such vesting date.

Read SEC document
March 10, 2025 Filed Mar 13, 2025 00:04 UTC GrantRestricted Stock Units · Derivative 23,840 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-023077 · tm259047-2_4seq1.xml · derivative · entry 2

Shiver John W. · CIK 0001900372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,840

Underlying: Common Stock · 23,840 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.

F3 · derivative.exercise_date: The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date.

F3 · derivative.expiration_date: The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date.

Read SEC document
March 10, 2025 Filed Mar 13, 2025 00:04 UTC GrantStock Option (Right to buy) · Derivative 35,770 $0.00 Strike: $8.20 $0.00
Disclosure

SEC source: 0001104659-25-023077 · tm259047-2_4seq1.xml · derivative · entry 1

Shiver John W. · CIK 0001900372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,770

Underlying: Common Stock · 35,770 shares

Expires 2035-03-10

F1 · derivative.exercise_date: The shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest with respect to one-third (1/3) of the shares on each of the first three (3) anniversaries of the March 10, 2025 grant date (the "Grant Date"), in each case subject to continued service on the Company's Board of Directors through such vesting date.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 20:34 UTC
Trizzino JohnPresident and COO
Exercise / conversionRestricted Stock Units · Derivative 28,890 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000333 · primary_01.xml · derivative · entry 3

Trizzino John · CIK 0001468534 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,890

Underlying: Common Stock · 28,890 shares

Expires 2033-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 20:34 UTC
Trizzino JohnPresident and COO
Tax withholdingCommon Stock 13,954 $8.34 $116,376.36
Disclosure

SEC source: 0001593968-25-000333 · primary_01.xml · nonDerivative · entry 2

Trizzino John · CIK 0001468534 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,061

Read SEC document
March 07, 2025 Filed Mar 11, 2025 20:34 UTC
Trizzino JohnPresident and COO
Exercise / conversionCommon Stock 28,890 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000333 · primary_01.xml · nonDerivative · entry 1

Trizzino John · CIK 0001468534 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,015

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 20:33 UTC
Kelly James PatrickEVP, CFO and Treasurer
Exercise / conversionRestricted Stock Units · Derivative 12,223 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000332 · primary_01.xml · derivative · entry 3

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,223

Underlying: Common Stock · 12,223 shares

Expires 2033-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 20:33 UTC
Kelly James PatrickEVP, CFO and Treasurer
Tax withholdingCommon Stock 5,904 $8.34 $49,239.36
Disclosure

SEC source: 0001593968-25-000332 · primary_01.xml · nonDerivative · entry 2

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,251

Read SEC document
March 07, 2025 Filed Mar 11, 2025 20:33 UTC
Kelly James PatrickEVP, CFO and Treasurer
Exercise / conversionCommon Stock 12,223 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000332 · primary_01.xml · nonDerivative · entry 1

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,155

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:07 UTC
Casey Mark JEVP, Chief Legal Officer
Grant2025 Restricted Stock Units RSU · Derivative 112,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000306 · primary_01.xml · derivative · entry 2

Casey Mark J · CIK 0001415297 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,500

Underlying: Common Stock · 112,500 shares

Expires 2035-03-03

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:07 UTC
Casey Mark JEVP, Chief Legal Officer
Grant2025 Non-statutory Stock Option NQ · Derivative 169,000 $7.87 Strike: $7.87 $1,330,030.00
Disclosure

SEC source: 0001593968-25-000306 · primary_01.xml · derivative · entry 1

Casey Mark J · CIK 0001415297 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,000

Underlying: Common Stock · 169,000 shares

Expires 2035-03-03

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:04 UTC Grant2025 Restricted Stock Units RSU · Derivative 80,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000305 · primary_01.xml · derivative · entry 2

Draghia-Akli Ruxandra · CIK 0002041719 · Section 16

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-03-03

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:04 UTC Grant2025 Non-statutory Stock Option NQ · Derivative 120,000 $7.87 Strike: $7.87 $944,400.00
Disclosure

SEC source: 0001593968-25-000305 · primary_01.xml · derivative · entry 1

Draghia-Akli Ruxandra · CIK 0002041719 · Section 16

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2035-03-03

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:03 UTC
Jacobs John CDirector · President and CEO
Grant2025 Restricted Stock Units RSU · Derivative 450,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000304 · primary_01.xml · derivative · entry 2

Jacobs John C · CIK 0001820836 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,500

Underlying: Common Stock · 450,500 shares

Expires 2035-03-03

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:03 UTC
Jacobs John CDirector · President and CEO
Grant2025 Non-statutory Stock Option NQ · Derivative 676,000 $7.87 Strike: $7.87 $5,320,120.00
Disclosure

SEC source: 0001593968-25-000304 · primary_01.xml · derivative · entry 1

Jacobs John C · CIK 0001820836 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 676,000

Underlying: Common Stock · 676,000 shares

Expires 2035-03-03

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:02 UTC
O'Hara ElaineEVP, Chief Strategy Officer
Grant2025 Restricted Stock Units RSU · Derivative 169,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000303 · primary_01.xml · derivative · entry 2

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,000

Underlying: Common Stock · 169,000 shares

Expires 2035-03-03

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:02 UTC
O'Hara ElaineEVP, Chief Strategy Officer
Grant2025 Non-statutory Stock Option NQ · Derivative 253,500 $7.87 Strike: $7.87 $1,995,045.00
Disclosure

SEC source: 0001593968-25-000303 · primary_01.xml · derivative · entry 1

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,500

Underlying: Common Stock · 253,500 shares

Expires 2035-03-03

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:01 UTC
Kelly James PatrickEVP, CFO and Treasurer
Grant2025 Restricted Stock Units RSU · Derivative 129,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000302 · primary_01.xml · derivative · entry 2

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,500

Underlying: Common Stock · 129,500 shares

Expires 2035-03-03

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 22:01 UTC
Kelly James PatrickEVP, CFO and Treasurer
Grant2025 Non-statutory Stock Option NQ · Derivative 194,500 $7.87 Strike: $7.87 $1,530,715.00
Disclosure

SEC source: 0001593968-25-000302 · primary_01.xml · derivative · entry 1

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,500

Underlying: Common Stock · 194,500 shares

Expires 2035-03-03

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:47 UTC
Trizzino JohnPresident and COO
Exercise / conversionRestricted Stock Units · Derivative 48,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000289 · primary_01.xml · derivative · entry 3

Trizzino John · CIK 0001468534 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,000

Underlying: Common Stock · 48,000 shares

Expires 2034-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:47 UTC
Trizzino JohnPresident and COO
Tax withholdingCommon Stock 23,185 $8.33 $193,131.05
Disclosure

SEC source: 0001593968-25-000289 · primary_01.xml · nonDerivative · entry 2

Trizzino John · CIK 0001468534 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,125

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:47 UTC
Trizzino JohnPresident and COO
Exercise / conversionCommon Stock 48,000 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000289 · primary_01.xml · nonDerivative · entry 1

Trizzino John · CIK 0001468534 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,310

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:46 UTC
Casey Mark JEVP, Chief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 4,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000288 · primary_01.xml · derivative · entry 3

Casey Mark J · CIK 0001415297 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 4,000 shares

Expires 2034-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:46 UTC
Casey Mark JEVP, Chief Legal Officer
Tax withholdingCommon Stock 1,214 $8.33 $10,112.62
Disclosure

SEC source: 0001593968-25-000288 · primary_01.xml · nonDerivative · entry 2

Casey Mark J · CIK 0001415297 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,973

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:46 UTC
Casey Mark JEVP, Chief Legal Officer
Exercise / conversionCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000288 · primary_01.xml · nonDerivative · entry 1

Casey Mark J · CIK 0001415297 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,187

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:43 UTC
Kelly James PatrickEVP, CFO and Treasurer
Exercise / conversionRestricted Stock Units · Derivative 58,667 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000287 · primary_01.xml · derivative · entry 3

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,333

Underlying: Common Stock · 58,667 shares

Expires 2034-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:43 UTC
Kelly James PatrickEVP, CFO and Treasurer
Tax withholdingCommon Stock 28,337 $8.33 $236,047.21
Disclosure

SEC source: 0001593968-25-000287 · primary_01.xml · nonDerivative · entry 2

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,932

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:43 UTC
Kelly James PatrickEVP, CFO and Treasurer
Exercise / conversionCommon Stock 58,667 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000287 · primary_01.xml · nonDerivative · entry 1

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,269

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:42 UTC
Jacobs John CDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 83,334 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000286 · primary_01.xml · derivative · entry 3

Jacobs John C · CIK 0001820836 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,666

Underlying: Common Stock · 83,334 shares

Expires 2034-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:42 UTC
Jacobs John CDirector · President and CEO
Tax withholdingCommon Stock 38,451 $8.33 $320,296.83
Disclosure

SEC source: 0001593968-25-000286 · primary_01.xml · nonDerivative · entry 2

Jacobs John C · CIK 0001820836 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,732

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:42 UTC
Jacobs John CDirector · President and CEO
Exercise / conversionCommon Stock 83,334 $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000286 · primary_01.xml · nonDerivative · entry 1

Jacobs John C · CIK 0001820836 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,183

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 23:39 UTC
O'Hara ElaineEVP, Chief Strategy Officer
Exercise / conversionRestricted Stock Units · Derivative 40,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001593968-25-000285 · primary_01.xml · derivative · entry 6

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 40,000 shares

Expires 2034-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.